Xenon Pharmaceuticals Inc - Company Profile
Powered by 
All the sales intelligence you need on Xenon Pharmaceuticals Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Xenon Pharmaceuticals Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Xenon Pharmaceuticals Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Xenon Pharmaceuticals Inc (Xenon) is a neuroscience-focused biopharmaceutical company that discovers, develops and devlivers life-changing therapeutics. The company offers azetukalner, is a novel, potent Kv7 potassium channel opener developed for the treatment of epilepsy, major depressive disorder, and other neurological disorders. Its pipeline products include X-TOLE2 and X-TOLE3, which treats epilepsy focal onset seizures (FOS); X-ACKT for epilepsy primary generalized tonic-clonic seizures (PGTCS); and X-NOVA2 which targets major depressive disorder (MDD). The company operates in Canada and the US. Xenon is headquartered in Burnaby, British Columbia, Canada.
Headquarters
Canada
Address
3650 Gilmore Way, Vancouver, British Columbia, V5G4W8
Website
www.xenon-pharma.com
Telephone
1 604 4843300
No of Employees
358
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
XENE (NASD)
Revenue (2025)
$7.5M
EPS
XYZ
Net Income (2025)
XYZ
-47.6%
(2025 vs 2024)
Market Cap*
$5.8B
Net Profit Margin (2025)
XYZ
-978.0%
(2025 vs 2024)
* As of and is in US$
Xenon Pharmaceuticals Inc premium industry data and analytics
Products and Services
| Products |
|---|
| Pipeline |
| Azetukalner: |
| Epilepsy |
| XYZ |
| XYZ |
| XYZ |
Competitor Comparison
| Key Parameters | Xenon Pharmaceuticals Inc | AbbVie Inc | Neurocrine Biosciences Inc | Supernus Pharmaceuticals Inc | Intra-Cellular Therapies Inc |
|---|---|---|---|---|---|
| Headquarters | Canada | United States of America | United States of America | United States of America | United States of America |
| City | Vancouver | North Chicago | San Diego | Rockville | Bedminster |
| State/Province | British Columbia | Illinois | California | Maryland | New Jersey |
| No. of Employees | 358 | 57,000 | 2,000 | 778 | 860 |
| Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Dawn Svoronos | Chairman | Executive Board | 2024 | 71 |
| Ian Mortimer | Director; President; Chief Executive Officer | Executive Board | 2021 | 49 |
| Tucker Kelly | Chief Financial Officer | Senior Management | 2025 | - |
| Matthew D. Ronsheim, Ph.D. | Chief Operating Officer | Senior Management | 2024 | - |
| Andrea DiFabio | Corporate Secretary; Chief Legal Officer | Senior Management | 2022 | 56 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer